Predictive Values of Blood-Based RNA Signatures for the Gemcitabine Response in Advanced Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic adenocarcinoma is predicted to be the 2nd cause of death by cancer in Western Countries in 2023. Most patients are diagnosed at an advanced stage for which chemotherapy is the main treatment. In this study we developed through an innovative approach, a simple nine genes bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Piquemal, David, Noguier, Florian, Pierrat, Fabien, Bruno, Roman, Cros, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692046/
https://www.ncbi.nlm.nih.gov/pubmed/33143297
http://dx.doi.org/10.3390/cancers12113204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692046/
https://www.ncbi.nlm.nih.gov/pubmed/33143297
http://dx.doi.org/10.3390/cancers12113204

Ejemplares similares